BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37788904)

  • 1. Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink.
    Roddy E; Bajpai R; Forrester H; Partington RJ; Mallen CD; Clarson LE; Padmanabhan N; Whittle R; Muller S
    Ann Rheum Dis; 2023 Dec; 82(12):1618-1625. PubMed ID: 37788904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for colchicine prophylaxis-related adverse events when initiating allopurinol for gout: retrospective cohort study.
    Bajpai R; Partington R; Muller S; Forrester H; Mallen CD; Clarson L; Padmanabhan N; Whittle R; Roddy E
    Rheumatology (Oxford); 2024 Apr; ():. PubMed ID: 38636489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How common are side effects of treatment to prevent gout flares when starting allopurinol?
    Saul H; Deeney B; Swaithes L; Roddy E
    BMJ; 2024 Mar; 384():q514. PubMed ID: 38458626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline.
    Shekelle PG; Newberry SJ; FitzGerald JD; Motala A; O'Hanlon CE; Tariq A; Okunogbe A; Han D; Shanman R
    Ann Intern Med; 2017 Jan; 166(1):37-51. PubMed ID: 27802478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England.
    Russell MD; Roddy E; Rutherford AI; Ellis B; Norton S; Douiri A; Gulliford MC; Cope AP; Galloway JB
    Rheumatology (Oxford); 2023 Jul; 62(7):2426-2434. PubMed ID: 36355461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drugs for acute gout.
    van Durme CM; Wechalekar MD; Landewé RB; Pardo Pardo J; Cyril S; van der Heijde D; Buchbinder R
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD010120. PubMed ID: 34882311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine for acute gout.
    van Echteld I; Wechalekar MD; Schlesinger N; Buchbinder R; Aletaha D
    Cochrane Database Syst Rev; 2014 Aug; (8):CD006190. PubMed ID: 25123076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of appropriate duration of colchicine prophylaxis to maximize the persistence of xanthine oxidase inhibitors as the first-line urate-lowering therapy in patients with gout using the Korean Health Insurance Review and Assessment Service database.
    So MW; Kim AR; Lee SG
    Int J Rheum Dis; 2023 Sep; 26(9):1770-1778. PubMed ID: 37431263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors.
    Wechalekar MD; Vinik O; Moi JH; Sivera F; van Echteld IA; van Durme C; Falzon L; Bombardier C; Carmona L; Aletaha D; Landewé RB; van der Heijde DM; Buchbinder R
    J Rheumatol Suppl; 2014 Sep; 92():15-25. PubMed ID: 25180124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.
    Yamanaka H; Tamaki S; Ide Y; Kim H; Inoue K; Sugimoto M; Hidaka Y; Taniguchi A; Fujimori S; Yamamoto T
    Ann Rheum Dis; 2018 Feb; 77(2):270-276. PubMed ID: 29102957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Colchicine Prophylaxis for Gout Flares When Commencing Allopurinol.
    Robinson PC; Dalbeth N; Donovan P
    Arthritis Care Res (Hoboken); 2021 Oct; 73(10):1537-1543. PubMed ID: 32558298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
    Becker MA; Fitz-Patrick D; Choi HK; Dalbeth N; Storgard C; Cravets M; Baumgartner S
    Semin Arthritis Rheum; 2015 Oct; 45(2):174-83. PubMed ID: 26190562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data.
    Singh JA; Cleveland JD
    Ann Rheum Dis; 2020 Apr; 79(4):529-535. PubMed ID: 32024648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study.
    Dennison EM; Rubin KH; Schwarz P; Harvey NC; Bone KW; Cooper C; Abrahamsen B
    Arch Osteoporos; 2015; 10():36. PubMed ID: 26481934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of allopurinol on risk of myocardial infarction.
    Grimaldi-Bensouda L; Alpérovitch A; Aubrun E; Danchin N; Rossignol M; Abenhaim L; Richette P;
    Ann Rheum Dis; 2015 May; 74(5):836-42. PubMed ID: 24395556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.
    Mackenzie IS; Ford I; Nuki G; Hallas J; Hawkey CJ; Webster J; Ralston SH; Walters M; Robertson M; De Caterina R; Findlay E; Perez-Ruiz F; McMurray JJV; MacDonald TM;
    Lancet; 2020 Nov; 396(10264):1745-1757. PubMed ID: 33181081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment.
    Vargas-Santos AB; Peloquin CE; Zhang Y; Neogi T
    JAMA Intern Med; 2018 Nov; 178(11):1526-1533. PubMed ID: 30304329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopurinol for chronic gout.
    Seth R; Kydd AS; Buchbinder R; Bombardier C; Edwards CJ
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD006077. PubMed ID: 25314636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of low-dose versus regular-dose colchicine to prevent flares in gout patients initiated on urate-lowering therapies.
    Ahn SM; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
    Rheumatology (Oxford); 2021 Dec; 61(1):223-229. PubMed ID: 33764413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.